Table 3 Comparison of two ERCPs related adverse events and outcomes in Group B (n = 64)
First ERCP(n = 64) | Second ERCP(n = 64) | P values | |
|---|---|---|---|
Diameter of the CBD stone (cm), mean ± SD | 1.95 ± 0.543 | 1.59 ± 0.544 | <0.001 |
Procedure time (min), mean ± SD | 20.48 ± 11.975 | 36.70 ± 16.411 | <0.001 |
Hospital stay (days), mean ± SD | 10.11 ± 2.885 | 9.47 ± 1.681 | 0.132 |
Postprocedure adverse events, n(%) | 12(18.8%) | 7(10.9%) | 0.214 |
Post-ERCP pancreatitis | 8(12.5%) | 2(3.1%) | 0.048 |
Bleeding | 1(1.6%) | 1(1.6%) | 1.000 |
Perforation | 0 | 0 | NA |
Cholangitis/Cholecystitis | 0 | 2(3.1%) | 0.496 |
Pneumonia | 3(4.7%) | 2(3.1%) | 0.648 |
Cardio-cerebrovascular events | 0 | 0 | NA |